Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vancomycin for Sternal Wound Infection
NCT02374853Phase 2Terminated
- Sponsor
- University of Alberta
- Start
- Mar 2015
- Primary completion
- Apr 2019
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 2 trial of vancomycin in sternal wound infection, sponsored by University of Alberta. Started Mar 2015; status: terminated.
02
Drugs
vancomycin
03
Conditions
sternal wound infection
Beyond the preview
Go deeper on NCT02374853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374853.